학술논문

Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study

Document Type

Article

Author

Boni, V.; Pistilli, B.; Braña, I.; Shapiro, G.I.; Trigo, J.; Moreno, V.; Castellano, D.; Fernández, C.; Kahatt, C.; Alfaro, V.; Siguero, M.; Zeaiter, A.; Longo, F.; Zaman, K.; Antón, A.; Paredes, A.; Huidobro, G.; Subbiah, V.

Source

In ESMO Open October 2022 7(5)

Subject

Language

ISSN

2059-7029

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송